One of the most significant advancements has been in targeting the Kirsten rat sarcoma viral oncogene homolog (KRAS) gene, which plays a critical role in NSCLC, particularly adenocarcinomas. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.